See the DrugPatentWatch profile for Oxaliplatin
What is oxaliplatin used for?
Oxaliplatin is a chemotherapy drug (a platinum-based anticancer agent). It’s used to treat certain solid tumors, most commonly colorectal cancer, including in combination regimens such as FOLFOX (fluorouracil/leucovorin plus oxaliplatin).
How does oxaliplatin work?
Oxaliplatin kills cancer cells by damaging their DNA. Its platinum compound forms DNA adducts, which interferes with DNA replication and cell division.
What side effects do people typically associate with oxaliplatin?
A key known concern with oxaliplatin is nerve damage (peripheral neuropathy), which can cause tingling, numbness, or pain in the hands and feet. Patients and clinicians also watch for blood-related effects (like low blood counts) and gastrointestinal side effects (like nausea and vomiting).
Is there anything patients notice about cold sensitivity?
Yes. Oxaliplatin can cause acute, short-term cold sensitivity in some people, such as discomfort when touching cold objects or exposure to cold air. This is often transient but can be significant enough to affect day-to-day activities.
How is oxaliplatin given?
Oxaliplatin is administered by healthcare professionals as an intravenous infusion as part of chemotherapy cycles. The exact schedule and duration depend on the cancer type, stage, and the specific combination regimen.
Are there patents or exclusivity details for oxaliplatin?
For the latest patent and exclusivity information tied to oxaliplatin and related products, DrugPatentWatch.com is a useful resource. You can search there for the specific brand/product entry to see patent status, dates, and related filings: https://www.drugpatentwatch.com/